GlassScriptPhysician profile
Erin M Frank
NPI 1396129458
$14,781.78
in general payments reported to CMS, 2019-2025
71 companies · $3,323 in 2025
The $3,323 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $434 · 2022: $2,813 · 2023: $4,364 · 2024: $3,848 · 2025: $3,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,308 · Long Term Medical Supply Or Device Loan: $2,115 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,307.64 |
| Long Term Medical Supply Or Device Loan | $2,114.51 |
| Education | $112.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,073.61 | 2022-2025 | |
| Janssen Biotech, INC. | $1,051.77 | 2021-2025 | Darzalex, Talvey, Rybrevant |
| Merck Sharp & Dohme LLC | $930.29 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Incyte Corporation | $565.55 | 2021-2025 | Monjuvi, Jakafi, Pemazyre |
| Pfizer INC. | $534.87 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $472.32 | 2022-2025 | Imfinzi, Calquence, Lynparza |
| Daiichi Sankyo INC. | $464.16 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Seagen INC. | $440.30 | 2021-2025 | Adcetris, Tivdak, Tukysa |
| Regeneron Healthcare Solutions, INC. | $400.73 | 2022-2025 | Libtayo, Lynozyfic |
| Genentech USA, INC. | $389.20 | 2022-2025 | Polivy, Lunsumio, Venclexta |
| Eisai INC. | $375.56 | 2022-2025 | |
| Abbvie INC. | $353.52 | 2023-2025 | |
| Pharmacosmos Therapeutics INC. | $280.83 | 2022-2025 | Monoferric |
| Amgen INC. | $265.00 | 2022-2024 | Xgeva, Nplate, Vectibix |
| Astellas Pharma US INC | $258.71 | 2022-2025 | Padcev, Xtandi, Vyloy |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $252.00 | 2022-2025 | Opdivo, Eliquis |
| Takeda Pharmaceuticals U.S.A., INC. | $249.52 | 2022-2024 | Fruzaqla, Iclusig, Alunbrig |
| Pharmacyclics LLC, An Abbvie Company | $232.88 | 2022-2023 | Imbruvica, Epkinly |
| Beigene USA, INC. | $230.78 | 2022-2024 | Brukinsa |
| Bayer Healthcare Pharmaceuticals INC. | $209.75 | 2022-2025 | |
| Array Biopharma INC | $201.65 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Genzyme Corporation | $198.94 | 2022-2025 | |
| Lilly USA, LLC | $190.47 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Stemline Therapeutics INC. | $164.66 | 2023-2024 | Orserdu |
| Exelixis INC. | $155.40 | 2023-2024 | Cabometyx |
| Puma Biotechnology, INC. | $149.52 | 2023-2025 | Nerlynx |
| Alexion Pharmaceuticals, INC. | $143.42 | 2022-2024 | Ultomiris |
| Aveo Pharmaceuticals, INC. | $138.92 | 2022-2023 | Fotivda |
| Pharmaessentia USA Corporation | $125.07 | 2022-2025 | Besremi |
| Sobi, INC | $124.08 | 2022-2025 | |
| Celgene Corporation | $112.71 | 2022-2023 | Reblozyl, Opdualag |
| Rigel Pharmaceuticals, INC. | $111.34 | 2022-2024 | Rezlidhia, Tavalisse |
| Gilead Sciences, INC. | $107.98 | 2021-2025 | Trodelvy |
| Adc Therapeutics America, INC. | $107.67 | 2022-2025 | |
| Global Blood Therapeutics, INC. | $107.10 | 2022 | |
| Mirati Therapeutics, INC. | $103.51 | 2023-2024 | Krazati |
| Ipsen Biopharmaceuticals, INC | $103.18 | 2023-2024 | Onivyde, Somatuline Depot, Tazverik |
| Glaxosmithkline, LLC. | $99.26 | 2022-2025 | Jemperli, Zejula, Trelegy Ellipta |
| Morphosys, US INC. | $89.36 | 2022-2024 | Monjuvi |
| Taiho Oncology, INC. | $87.99 | 2022-2024 | |
| Kyowa Kirin, INC. | $86.90 | 2023-2025 | Poteligeo |
| Tersera Therapeutics LLC | $81.63 | 2023-2024 | Xermelo, Zoladex, Quzyttir |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.61 | 2022-2025 | |
| Beone Medicines USA, INC. | $75.58 | 2025 | Brukinsa |
| Eusa Pharma (US) LLC | $64.07 | 2022 | |
| Emd Serono, INC. | $60.80 | 2024-2025 | |
| Heron Therapeutics, INC. | $54.07 | 2022-2023 | Sustol |
| Kite Pharma, INC. | $46.50 | 2022-2023 | |
| Spectrum Pharmaceuticals INC. | $46.38 | 2023-2025 | Rolvedon |
| Caris Mpi, INC. | $46.14 | 2025 | Mi Cancer Seek |
| Deciphera Pharmaceuticals INC. | $35.24 | 2023-2025 | Qinlock, Romvimza |
| Alnylam Pharmaceuticals INC. | $35.19 | 2023-2024 | Givlaari |
| Blue Earth Diagnostics | $34.70 | 2023 | |
| Genmab U.S., INC. | $32.16 | 2024 | Epkinly |
| Agios Pharmaceuticals, INC. | $30.41 | 2024 | Pyrukynd |
| Syndax Pharmaceuticals, INC. | $29.55 | 2025 | |
| Adaptive Biotechnologies Corporation | $25.48 | 2025 | Clonoseq |
| G1 Therapeutics, INC. | $24.14 | 2023 | Cosela |
| Myovant Sciences INC. | $24.09 | 2022 | |
| Biocon Biologics INC | $23.27 | 2024 | Ogivri |
| Legend Biotech USA INC. | $23.22 | 2025 | Carvykti |
| Accord Healthcare, INC. | $21.03 | 2025 | |
| Blueprint Medicines Corporation | $21.01 | 2023 | Ayvakit |
| Coherus Oncology, INC. | $19.91 | 2025 | Loqtorzi |
| Servier Pharmaceuticals LLC | $18.22 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.64 | 2024 | Xarelto |
| Sumitomo Pharma America, INC. | $16.52 | 2023 | Orgovyx |
| Acrotech Biopharma INC. | $16.04 | 2024 | Beleodaq |
| Foundation Medicine, INC. | $14.92 | 2023 | |
| Cti Biopharma Corp. | $14.88 | 2023 | Vonjo |
| Myriad Genetic Laboratories, INC. | $12.90 | 2023 | Precisetumor |
Drugs and devices associated with these payments
Kisqali $2,309Keytruda $724Libtayo $336Lenvima $333Enhertu $288Imbruvica $268Lynparza $268Xtandi $250Venclexta $230Darzalex $224Orgovyx $199Brukinsa $185Braftovi $182Monoferric $181Monjuvi $174Talvey $171Rybrevant $167Orserdu $165Talzenna $163Mektovi $157Polivy $156Tecvayli $155Cabometyx $155Fabhalta $150Imfinzi $146Xofigo $140Verzenio $138Jaypirca $135Lunsumio $133Xgeva $131Nplate $131Nubeqa $131Calquence $122Ibrance $119Ultomiris $119Keytruda Qlex $117Welireg $106Vectibix $105Adcetris $105Pluvicto $104Krazati $104Lorbrena $99.48Gazyva $97.91Besremi $96.32Padcev $92.74Sarclisa $90.35Epkinly $88.59Poteligeo $86.90Erleada $86.00Eliquis $84.73Jakafi $83.75Rezlidhia $80.78Tavalisse $80.78Columvi $79.92Somatuline Depot $79.04Onivyde $79.04Lutathera $77.64Nerlynx $77.12Scemblix $73.07Fruzaqla $72.10Opdivo $71.24Promacta $69.94Inqovi $68.37Lonsurf $68.37Tivdak $67.97Piqray $66.87Doptelet $64.53Tabrecta $61.24Tukysa $60.31Elahere $59.49Elrexfio $58.86Pemazyre $52.66Carvykti $50.85Tecentriq $48.85Paxlovid $48.63Trodelvy $46.72Rolvedon $46.38Mi Cancer Seek $46.14Phesgo $45.41Vonjo $42.26Stivarga $40.38Qinlock $35.24Givlaari $35.19Posluma $34.70Axumin $34.70Iclusig $34.34Alunbrig $34.29Jevtana $33.23Jemperli $32.73Zejula $32.73Fotivda $32.25Mekinist $31.44Retevmo $31.26Pyrukynd $30.41Xermelo $29.16Sustol $29.11Injectafer $29.07Lumakras $29.07Vyloy $28.97Elitek $28.65
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.